Literature DB >> 17226842

Interstitial brachytherapy for childhood soft tissue sarcoma.

Siddhartha Laskar1, Gaurav Bahl, Mary Ann Muckaden, Ajay Puri, Manish G Agarwal, Nikhilesh Patil, Shyam K Shrivastava, Ketayun A Dinshaw.   

Abstract

BACKGROUND: To evaluate the efficacy of interstitial brachytherapy (BRT) in children undergoing combined modality treatment for soft tissue sarcomas (STS). PROCEDURE: From September 1984 to December 2003, 50 children (median age 13 years, range 1 to 18) with STS who received BRT as part of loco-regional treatment were included. There were 30 males and 20 females, the majority (68%) had primary lesions, synovial sarcoma (32%) was the most common histological type, and 26% had high-grade lesions. Treatment included wide local excision and BRT with or without external beam radiotherapy (EBRT). Thirty children (60%) received BRT alone.
RESULTS: After a median follow-up of 51 months, the local control (LC), disease-free survival, and overall survival were 82%, 68%, and 71%, respectively. LC was superior in patients with tumor size </=5 cm versus >5 cm (96% vs. 67%, P = 0.04), symptom duration <2 months versus >2 months (100% vs. 73%, P = 0.05), and Grade I versus Grade II versus Grade III tumors (100% vs. 93% vs. 57%, P = 0.03). Children receiving a combination of BRT and EBRT had comparable LC to those receiving BRT alone (78% vs. 84%, P = 0.89). There was no significant difference in LC for patients receiving LDR versus HDR BRT (77% vs. 92%, P = 0.32, for BRT alone; and 67% vs. 100%, P = 0.17, for BRT + EBRT).
CONCLUSION: Interstitial BRT with or without EBRT appears to result in satisfactory outcome in children with STS. Radical BRT alone, when used judiciously in select groups of children, results in excellent local control and functional outcome with reduced treatment-related morbidity. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17226842     DOI: 10.1002/pbc.21118

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

Review 1.  Progress in radiotherapy for pediatric sarcomas.

Authors:  Susan L McGovern; Anita Mahajan
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

Review 2.  Non-rhabdomyosarcoma soft-tissue sarcomas in children: Contemporary appraisal and experience from a single centre.

Authors:  Sajid S Qureshi; Monica Bhagat
Journal:  J Indian Assoc Pediatr Surg       Date:  2015 Oct-Dec

3.  Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report.

Authors:  Julie A Bradley; Sara H Kleinman; Jason Rownd; David King; Donald Hackbarth; Robert Whitfield; Dian Wang
Journal:  J Contemp Brachytherapy       Date:  2011-03-31

4.  Interstitial brachytherapy in soft tissue sarcoma: a 5 years institutional experience with Cobalt 60-based high-dose-rate brachytherapy system.

Authors:  Kazi Sazzad Manir; Abhishek Basu; Krishnangshu B Choudhury; Swapnendu Basu; Koushik Ghosh; Subir Gangopadhyay
Journal:  J Contemp Brachytherapy       Date:  2018-10-31

5.  Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).

Authors:  Barbara Röper; Christine Heinrich; Victoria Kehl; Hans Rechl; Katja Specht; Klaus Wörtler; Andreas Töpfer; Michael Molls; Severin Kampfer; Rüdiger von Eisenharth-Rothe; Stephanie E Combs
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

Review 6.  Indian data on bone and soft tissue sarcomas: A summary of published study results.

Authors:  Anant Ramaswamy; Bharat Rekhi; Sameer Bakhshi; Sachin Hingmire; Manish Agarwal
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.